Clinical Trial Update: SSR240600C Treatment in Women With Overactive Bladder [Phase 2]

View source ↗

Summary

Phase 2 trial update for SSR240600C in women with overactive bladder; the study status is listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• SSR240600C

Snippet

Sponsor: Sanofi | Conditions: Overactive Bladder | Phase 2 | Status: COMPLETED